New combo therapy aims to extend life without sacrificing quality in advanced head and neck cancer
NCT ID NCT03070366
First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 32 times
Summary
This study looks at adults with head and neck cancer that has spread to 1-3 other spots (oligometastases). It compares two treatments: stereotactic radiotherapy alone versus radiotherapy plus chemotherapy. The goal is to see which approach helps people live longer with a good quality of life and fewer side effects. About 78 participants are being followed for one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Nord Franche Comté
Montbéliard, 25209, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.